Mayer Hany: Recombinant Activated FVII in Spontaneous Intracerebral Hemorrhage
Mayer Hany, Volunteer at Children’s Cancer Hospital Foundation, shared a post on LinkedIn about a recent article he and his colleagues co- authored, published in Journal of Clinical Neuroscience, adding:
“Proud to share my first publication!
Our systematic review and meta-analysis on the efficacy and safety of recombinant activated factor VII in spontaneous intracerebral hemorrhage, incorporating frequentist and Bayesian approaches with GRADE assessment, has been published in the Journal of Clinical Neuroscience (Q2).
Honored to be part of this work and grateful to all my co authors.
First step in evidence based medicine.”
Title: Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage
Authors: Stephan A Mayer, Nikolai C Brun, Kamilla Begtrup, Joseph Broderick, Stephen Davis, Michael N Diringer, Brett E Skolnick, Thorsten Steiner
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026